Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tingting Sun

Showing results (571-580 of 573) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 573 results.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
Pageof 58

Showing results (571-580 of 573) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 573 results.
Nature|September 3, 2015
The spliceosome is a therapeutic vulnerability in MYC-driven cancerTiffany Y-T Hsu, Lukas M Simon, Nicholas J Neill, et al.
Nature Medicine|March 27, 2018
Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancerAmritha Nair, Hsiang-Ching Chung, Tingting Sun, et al.
Cancer Discovery|August 8, 2025
Integrative proteogenomics and forward genetics reveals a novel mitotic vulnerability in triple-negative breast cancerNicholas J Neill, Shankha Satpathy, Karsten Krug, et al.
Pageof 58